Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Logothetis

Showing results (661-670 of 1,104) with videos related to

Pageof 111
Sort By:
Cancer Discovery|July 2, 2013
Molecular classification of prostate cancer progression: foundation for marker-driven treatment of prostate cancerChristopher J Logothetis, Gary E Gallick, Sankar N Maity, et al.
The International Journal of Artificial Organs|May 1, 1987
Serum ferroxidase I and II in uremic patients under conservative treatment and maintenance hemodialysisM Frangos-Plemenos, B Agroyannis, D Koutsicos, et al.
The Journal of Urology|January 1, 1989
Cisplatin, cyclophosphamide and doxorubicin chemotherapy for unresectable urothelial tumors: the M.D. Anderson experienceC J Logothetis, F H Dexeus, C Chong, et al.
Urologic Oncology|January 13, 2011
Clinical significance of elevation in neuroendocrine factors and interleukin-6 in metastatic prostate cancerN Hoosein, M Abdul, R McCabe, et al.
Urology|July 1, 1991
Serum biomarkers in metastatic renal cell carcinomaF H Dexeus, C J Logothetis, A Sella, et al.
Onkologie|September 7, 2004
Prognostic impact of EBV-related LMP-1, histologic type, and environmental factors in nasopharyngeal carcinoma in a German populationA Dietz, C A Logothetis, M Helbig, et al.
International Journal of Immunopathology and Pharmacology|January 4, 2006
A pilot, open label, clinical trial using hydroxyzine in multiple sclerosisL Logothetis, I A Mylonas, S Baloyannis, et al.
Journal of the National Cancer Institute|November 1, 2007
Adaptive therapy for androgen-independent prostate cancer: a randomized selection trial of four regimensPeter F Thall, Christopher Logothetis, Lance C Pagliaro, et al.
Urology|February 1, 1989
Small cell carcinoma of prostate associated with myasthenic (Eaton-Lambert) syndromeB Têtu, J Y Ro, A G Ayala, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2001
Integrated therapy for locally advanced bladder cancer: final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VACR Millikan, C Dinney, D Swanson, et al.
Pageof 111

Showing results (661-670 of 1,104) with videos related to

Sort By:
Pageof 111
Cancer Discovery|July 2, 2013
Molecular classification of prostate cancer progression: foundation for marker-driven treatment of prostate cancerChristopher J Logothetis, Gary E Gallick, Sankar N Maity, et al.
The International Journal of Artificial Organs|May 1, 1987
Serum ferroxidase I and II in uremic patients under conservative treatment and maintenance hemodialysisM Frangos-Plemenos, B Agroyannis, D Koutsicos, et al.
The Journal of Urology|January 1, 1989
Cisplatin, cyclophosphamide and doxorubicin chemotherapy for unresectable urothelial tumors: the M.D. Anderson experienceC J Logothetis, F H Dexeus, C Chong, et al.
Urologic Oncology|January 13, 2011
Clinical significance of elevation in neuroendocrine factors and interleukin-6 in metastatic prostate cancerN Hoosein, M Abdul, R McCabe, et al.
Urology|July 1, 1991
Serum biomarkers in metastatic renal cell carcinomaF H Dexeus, C J Logothetis, A Sella, et al.
Onkologie|September 7, 2004
Prognostic impact of EBV-related LMP-1, histologic type, and environmental factors in nasopharyngeal carcinoma in a German populationA Dietz, C A Logothetis, M Helbig, et al.
International Journal of Immunopathology and Pharmacology|January 4, 2006
A pilot, open label, clinical trial using hydroxyzine in multiple sclerosisL Logothetis, I A Mylonas, S Baloyannis, et al.
Journal of the National Cancer Institute|November 1, 2007
Adaptive therapy for androgen-independent prostate cancer: a randomized selection trial of four regimensPeter F Thall, Christopher Logothetis, Lance C Pagliaro, et al.
Urology|February 1, 1989
Small cell carcinoma of prostate associated with myasthenic (Eaton-Lambert) syndromeB Têtu, J Y Ro, A G Ayala, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2001
Integrated therapy for locally advanced bladder cancer: final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VACR Millikan, C Dinney, D Swanson, et al.
Pageof 111